Researchers have discovered a groundbreaking use of terahertz (THz) imaging to visualize cochlear structures in mice, offering non-invasive, high-resolution diagnostics. By creating 3D ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

Researchers have discovered a groundbreaking use of terahertz (THz) imaging to visualize cochlear structures in mice, offering non-invasive, high-resolution diagnostics. By creating 3D reconstructions ...

Terahertz imaging has been demonstrated to visualize the internal structures of the mouse cochlea with micron-level resolution, offering a non-invasive method for potential diagnosis of hearing ...

Depression affects millions of people worldwide, but much is still unknown about this illness and treatments don't always ...

Racial disparities among the use of prediagnostic MRI for the detection of prostate cancer shrank between 2012 and 2019, ...

A novel PET imaging approach can effectively quantify a key enzyme associated with brain inflammation, according to research ...

Lesions were better visualized on pTx than circularly polarized MRI in 57% of cases and were never better visualized on circularly polarized MRI.

Magnetic resonance imaging (MRI) is a non-invasive biomedical imaging technique that uses a strong oscillating magnetic field to induce endogenous atoms such as hydrogen, or exogenously added ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...